Effects of Bevacizumab, Ranibizumab, and Aflibercept on MicroRNA Expression in a Retinal Pigment Epithelium Cell Culture Model of Oxidative Stress.

Dinç, Erdem; Ayaz, Lokman; Kurt, Akif Hakan

<bold>Purpose: </bold>This study aimed to evaluate the effects of bevacizumab, ranibizumab, and aflibercept on the microRNA (miRNA) expression in human retinal pigment epithelium cell (ARPE-19) culture model of oxidative stress.<bold>Methods: </bold>Control cells were cultured in the hydrogen peroxide (H2O2)-free medium. In H2O2 group ARPE-19 cells were exposed to 600 μM H2O2 alone for 18 h. In study groups, cells were preincubated with bevacizumab, ranibizumab, and aflibercept (1.25-2.5, 0.5 and 2.0 mg/mL, respectively) for 3 h before H2O2 exposure. Another group of ARPE-19 cells were incubated with drugs for 3 h without H2O2 exposure. Cell viability and vascular endothelial growth factor (VEGF) levels were evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and enzyme-linked immunosorbent assay. The expression levels of 1,152 miRNAs were determined by quantitative real-time PCR.<bold>Results: </bold>Incubation with 600 μM H2O2 alone for 18 h decreased cell viability by ∼50%. Cell viability was greater in the anti-VEGF drug groups compared with the H2O2 group, but the differences were not significant (P > 0.05). VEGF levels were significantly lower in the anti-VEGF drug groups compared with the H2O2 group (P < 0.05 for all study groups), with no significant differences between the study groups (P > 0.05). Incubation with anti-VEGF drugs alone had no effect on miRNA expression in ARPE-19 cells. However, preincubation with bevacizumab, ranibizumab, and aflibercept significantly altered the profile of H2O2-modulated miRNA expression.<bold>Conclusions: </bold>Preincubation with anti-VEGF drugs can alter the miRNA expression profile in response to H2O2-induced oxidative stress, and these drugs may have epigenetic effects.

OXIDATIVE stress; CELLS; BEVACIZUMAB; RANIBIZUMAB; MICRORNA; RHODOPSIN; BIOLOGICAL models; CELL culture; CELL physiology; CELL receptors; COMPARATIVE studies; DOSE-effect relationship in pharmacology; RESEARCH methodology; MEDICAL cooperation; NEOVASCULARIZATION inhibitors; POLYMERASE chain reaction; RECOMBINANT proteins; RESEARCH; RNA; EVALUATION research; GENE expression profiling; PHARMACODYNAMICS

Journal of Ocular Pharmacology & Therapeutics, 2018, Vol 34, Issue 4, p346

1080-7683

Academic Journal

10.1089/jop.2017.0128